Cargando…

Identification of Therapeutic Targets for the Selective Killing of HBV-Positive Hepatocytes

The hepatitis B virus (HBV) infection is a major risk factor for cirrhosis and hepatocellular carcinoma. Most infected individuals become lifelong carriers of HBV as the drugs currently used to treat the patients can only control the disease, thereby achieving functional cure (loss of the hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Chien-Jung, Wang, Lily Hui-Ching, Wang, Yu-Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307716/ https://www.ncbi.nlm.nih.gov/pubmed/34357116 http://dx.doi.org/10.3390/jpm11070649

Ejemplares similares

Identification of Pre-Erythrocytic Malaria Antigens That Target Hepatocytes for Killing In Vivo and Contribute to Protection Elicited by Whole-Parasite Vaccination
por: Chen, Lin, et al.
Publicado: (2014)

The Interactions Between HBV and the Innate Immunity of Hepatocytes
por: Megahed, Fayed Attia Koutb, et al.
Publicado: (2020)

Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes
por: Yan, Ran, et al.
Publicado: (2015)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

ACE2 and TMPRSS2 Expression in Hepatocytes of Chronic HBV Infection Patients
por: Hu, Xiao-Xiao, et al.
Publicado: (2021)

TRAIL Dependent Fratricidal Killing of gp120 Primed Hepatocytes by HCV Core Expressing Hepatocytes
por: Rizza, Stacey A., et al.
Publicado: (2011)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Modulation of HBV replication by microRNA-15b through targeting hepatocyte nuclear factor 1α
por: Dai, Xiaopeng, et al.
Publicado: (2014)

Immunopeptidome of hepatocytes isolated from patients with HBV infection and hepatocellular carcinoma
por: de Beijer, Monique T.A., et al.
Publicado: (2022)

Liver damage favors the eliminations of HBV integration and clonal hepatocytes in chronic hepatitis B
por: Hu, Gang, et al.
Publicado: (2021)

Characterization of IL-21-expressing recombinant hepatitis B virus (HBV) as a therapeutic agent targeting persisting HBV infection
por: Shen, Zhongliang, et al.
Publicado: (2020)

Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes
por: Ancey, Pierre-Benoit, et al.
Publicado: (2015)

ATOH8 promotes HBV immune tolerance by inhibiting the pyroptotic pathway in hepatocytes
por: Liu, Xiaofei, et al.
Publicado: (2023)

Protection of Hepatocytes from Cytotoxic T Cell Mediated Killing by Interferon-Alpha
por: Willberg, Christian B., et al.
Publicado: (2007)

HBV cccDNA and Its Potential as a Therapeutic Target
por: Zhu, Anjing, et al.
Publicado: (2019)

Human Adipose-Derived Mesenchymal Stem Cells Are Resistant to HBV Infection during Differentiation into Hepatocytes in Vitro
por: Wang, Ying, et al.
Publicado: (2014)

Study of the expression levels of Hepatocyte nuclear factor 4 alpha and 3 beta in patients with different outcome of HBV infection
por: Chen, En-Qiang, et al.
Publicado: (2012)

Therapeutic targeting truncated adenomatous polyposis coli (APC) proteins for the selective killing of colorectal cancer cells
por: Zhang, Lu, et al.
Publicado: (2014)

Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes
por: Lucifora, Julie, et al.
Publicado: (2018)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Manske, Katrin, et al.
Publicado: (2021)

The emerging role of hepatitis B virus Pre-S2 deletion mutant proteins in HBV tumorigenesis
por: Su, Ih-Jen, et al.
Publicado: (2014)

Modeling to capture bystander-killing effect by released payload in target positive tumor cells
por: Byun, Jong Hyuk, et al.
Publicado: (2019)

Nepenthes Extract Induces Selective Killing, Necrosis, and Apoptosis in Oral Cancer Cells
por: Yang, Kun-Han, et al.
Publicado: (2021)

Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress
por: Chen, Huey-Ling, et al.
Publicado: (2012)

Tyrosine 146 of the Human Na(+)/Taurocholate Cotransporting Polypeptide (NTCP) Is Essential for Its Hepatitis B Virus (HBV) Receptor Function and HBV Entry into Hepatocytes
por: Zakrzewicz, Dariusz, et al.
Publicado: (2022)

Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production
por: Phillips, Sandra, et al.
Publicado: (2015)

Sgo1 is a potential therapeutic target for hepatocellular carcinoma
por: Wang, Lyu-Han, et al.
Publicado: (2015)

Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues
por: Srivastava, Mayank, et al.
Publicado: (2022)

Selective killing of cancer cells by nanoparticle-assisted ultrasound
por: Kosheleva, Olga K., et al.
Publicado: (2016)

Positive Selection and Horizontal Gene Transfer in the Genome of a Male-Killing Wolbachia
por: Hill, Tom, et al.
Publicado: (2021)

Metabolically Improved Stem Cell Derived Hepatocyte-Like Cells Support HBV Life Cycle and Are a Promising Tool for HBV Studies and Antiviral Drug Screenings
por: Tricot, Tine, et al.
Publicado: (2022)

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes
por: Takamatsu, Yuki, et al.
Publicado: (2023)

The Investigation of HBV Pre-S/S Gene Mutations in Occult HBV Infected Blood Donors with anti-HBs Positive
por: Guo, Yan, et al.
Publicado: (2022)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022)

Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia
por: Ma, Bohan, et al.
Publicado: (2022)

1054. A Randomized Controlled Trial of Hepatitis B virus (HBV) Revaccination among Men Who Have Sex with Men and Were Born in the Era of Universal Neonatal HBV Immunization
por: Huang, Yi-Chia, et al.
Publicado: (2020)

Selective killing of K-ras–transformed pancreatic cancer cells by targeting NAD(P)H oxidase
por: Wang, Peng, et al.
Publicado: (2015)

Targeted photodynamic therapy selectively kills activated fibroblasts in experimental arthritis
por: Dorst, Daphne N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ek40dmvk34ldfrclsbhslv4i2